After a grueling workweek, an anatomic pathologist took Saturday afternoon to play golf with his son. As he finished the 7th hole, he gets a cellphone call from a colleague. The surgeon conducting a liver transplant several hours away requested a liver specialist's review of the case. The pathologist tells his colleague to scan the slides and he'd review them on his iPad with Corista. 10 minutes later the case is diagnosed, the surgeon happy, the patient in better care, and the overworked pathologist and his son headed to the 8th tee box.
Ms. Wingard founded Corista with the goal of delivering a platform for physicians that would dramatically improve the delivery of pathology. With more than 25 years experience in business development, sales and marketing, Ms. Wingard has specialized in the introduction of innovative technologies for emerging markets. In previous positions, she was the key driver of growth for companies delivering technologies to Fortune 1000 companies in several industries, including healthcare, telecommunications, banking, and business process management. Ms. Wingard has built revenue streams of over $1B for the business ventures she’s led.
Prior to launching Corista, Ms. Wingard held senior executive positions in sales and business development for a wide range of technology–driven companies, including Op40, Vicorp, IBJ Schroder, Sprint and AT&T.
Ms. Wingard holds a BA and an MA from the University of Southern Mississippi.
Mr. Wirch joined Corista in 2008 to lead Corista’s platform architecture and product development. Mr. Wirch is focused on creating image-centric solutions for complex workflow and information management issues, emphasizing architecture, scalability, security and system availability. He has over 20 years of experience in the design and implementation of distributed and cloud-based computer systems, primarily for video and imaging systems. Mr. Wirch has designed and deployed solutions for some of the leading companies in video distribution and personalization, including Sequencia Technologies, Gotuit Media (acquired by Digitalsmiths), SeaChange International, The Analytical Sciences Corporation, and Metasignal.
Mr. Wirch represents Corista on the DICOM standards committee. He holds 2 granted patents and several more on file.
Mr. Wirch holds a B.S. in Computer Systems Engineering from Rensselaer Polytechnic Institute.
Keith J. Kaplan, MD serves as the company’s Chief Medical Officer. In this role, Dr. Kaplan contributes to both the development of Corista’s digital pathology platform, and to expanding the market awareness of how Corista’s platforms can materially improve the delivery of pathology while improving patient care.
Dr. Kaplan is board certified in anatomic and clinical pathology. A graduate of Michigan State University, and Northwestern University’s Feinberg School of Medicine, Dr. Kaplan completed his residency training in anatomic and clinical pathology at Walter Reed Army Medical Center, Washington, DC. While at Walter Reed, in conjunction with the Armed Forces Institute of Pathology, Dr. Kaplan founded and directed the Army Telepathology Program. This Program connected 25 hospitals internationally for consultation via telepathology
Dr. Kaplan was also with Mayo Clinic Rochester, Minnesota as an Associate Professor of Pathology of Mayo Medical School. At Carolinas Health Systems in Charlotte, NC, Dr. Kaplan held the Pathology Informatics Chair as CIO of Pathology practice.
Dr. Kaplan currently serves as a member of the College of American Pathologists, American Society of Clinical Pathology and the American Society of Cytopathology as well as the American Pathology Foundation. He is an executive board member of the American Pathology Foundation. Dr. Kaplan is the publisher of tissuepathology.com, the industry’s leading pathology blog, and a contributor to Corista’s blog.
Mr. Wechsler joined Corista in 2014 to chart the company’s financial path as the company enters a significant growth stage. His responsibilities span three key areas including operational finance, risk mitigation and the flow of funds. As a member of the senior management team he joins in assuring the delivery of value creation.
He has over 20 years of international financial management experience. His career began at Fechtor Detwiler in 1990 where he rose to Senior Vice President. He served at Morgan Stanley as a Sr. VP, growing and managing a $100+ million portfolio and participating in over 100 public equity deals. Mr. Wechsler also served as the Executive Director of International Equities and Fund Manager at Glitnir Bank in Iceland during a critical time in the country’s financial crisis. In that role, Mr. Wechsler led the Global Equities Fund to outperform benchmark by 700 basis points ahead of schedule with 1,200 basis point improvement/turnaround. During that time he was a regular lecturer on International Finance at the University of Reykjavik. He later rejoined Detwiler Fenton as their Chief Investment Officer; leading over 50 Capital Strategy pieces for both institutional and retail clients.
Mr. Boreing joined Corista in 2010, bringing 30 years of sales and business development experience to the company. Mr. Boreing’s experience in healthcare spans the industry’s earliest efforts in telemedicine and digital pathology to the present day.
As a Co-Founder and Director of Sales for Vidimedix, Mr. Boreing led the development of that company’s telemedicine applications for a variety of medical practice areas, including psychiatry, radiology, and general practice. Mr. Boreing also developed joint ventures with AT&T, Polycom, and IBM to expand the distribution channels for those applications.
When Vidimedix was acquired by Trestle in 2000, Mr. Boreing led Technical Sales for this Internet pioneer in the emerging field of digital pathology. Trestle’s early success included installations at the Department of Defense and major Medical Centers around the country. Mr. Boreing is a founder of the American Telemedicine Association.
Mr. Pace, Consulting Technologist for Euclid Discoveries, has authored nearly 90 worldwide patents in distributed systems, collaborative technologies, computer vision and image understanding. He is an expert technologist having developed innovative technologies in the areas of middleware, analytics, and compression technologies.
Mr. Pace’s experience includes leading mission-critical development efforts for large corporations such as Silknet (Kana), Sprint, and IBM, and building innovative technology platforms for emerging companies, including Euclid Discoveries and Op40.
Mr. Pace graduated from Clarkson University with dual Bachelor of Science degrees in Computer Science and Mathematics.
Mr. Wingard has 25 years of experience in medical imaging and healthcare technologies. Mr. Wingard has held senior executive positions at Access Radiology Corporation, an early provider of tele-radiology platform services, Tel-Care Inc., Multimedia Medical Systems and Vidimedix Corporation. As the senior executive for Sprint’s Healthcare efforts, Mr. Wingard designed and developed Sprint’s healthcare technology capability, HANDS™, which set the standard for telemedicine and tele-radiology. Prior to joining Sprint, Mr. Wingard directed AT&T’s Healthcare Industry’s Sales and Marketing efforts.
Since 1999, Mr. Wingard has been CEO of Euclid Discoveries, focused on the development of advanced technologies to optimize the delivery of high definition video. Euclid’s proprietary video compression methodology and Intellectual Property provides an improved user experience together with access to high definition video content that has been traditionally restricted by bandwidth.
Mr. Wingard graduated from the University of North Carolina at Charlotte with a BA degree in Psychology.
Mr. Lauro has 25 years of experience as a technology entrepreneur, operating executive, and venture capitalist. He was Managing Director/Partner at Wasserstein Perella and was Managing Director at Techfarm Ventures in Silicon Valley. He opened and managed Wasserstein’s tech investing office in Palo Alto, led and syndicated 18 private equity financing rounds and PE control deals, raised over $100M equity financing for portfolio companies and completed M&A transactions exceeding $1B in combined value. He has been a member of the board of directors of 17 public and private companies and has served as Interim CEO.
Earlier in his career, Mr. Lauro was Director of Rapid Commercialization at IBM headquarters where he led a team that launched new businesses based on advanced technology from IBM Watson Research labs including Silicon Germanium (SiGe), Speech Recognition and pervasive computing. George began his career designing inertial guidance systems at MIT/Draper Lab and Astronautics Corp. He holds 23 patents in inertial guidance GPS and RF devices.
Mr. Lauro attended Brown (BSEE), the Wharton School (MBA) and MIT (graduate studies in Aeronautical Engineering).